Skip to content

Insider · CIK 0001595930

Fink Jeffrey Arvin

Reports to the SEC for 1 company · SALT LAKE CITY, UT

Transactions

17

Companies

1

Filings

14

CIK

0001595930

Forms 4 and 5

Insider transactions

17 trades
DateCompanyValue
2025-06-04LPCNLipocine Inc. · Common Stock (Right to Buy)A Award+$5,644.8
2024-06-05LPCNLipocine Inc. · Common Stock (Right to Buy)A Award+$12.4K
2023-05-10LPCNLipocine Inc. · Common Stock (Right to Buy)A Award+$7,968
2022-06-08LPCNLipocine Inc. · Common Stock (Right to Buy)A Award+$20.2K
2021-06-09LPCNLipocine Inc. · Stock Option (Right to Buy)A Award+$27.7K
2020-12-16LPCNLipocine Inc.M Exercise/Conversion—
2020-12-16LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion—
2020-06-10LPCNLipocine Inc. · Stock Option (Right to Buy)A Award+$21.2K
2019-06-12LPCNLipocine Inc. · Stock Option (Right to Buy)A Award+$16.8K
2018-06-27LPCNLipocine Inc. · Stock Option (Right to Buy)A Award+$26.6K
2017-12-29LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion—
2017-12-29LPCNLipocine Inc.M Exercise/Conversion—
2017-12-29LPCNLipocine Inc.S Sale−$3,258.331
2017-01-26LPCNLipocine Inc. · Restricted Stock UnitA Award—
2016-06-14LPCNLipocine Inc. · Stock Option (Right to Buy)A Award+$80.2K
2015-06-16LPCNLipocine Inc. · Stock Option (Right to Buy)A Award—
2014-01-06LPCNLipocine Inc. · Stock Option (Right to Buy)A Award—

Recent filings

14

Companies

1

Address

C/O 675 ARAPEEN DR SUITE 202

SALT LAKE CITY, UT, 84108